tiprankstipranks
Trending News
More News >
Integrated BioPharma (INBP)
:INBP
US Market
Advertisement

Integrated BioPharma (INBP) Income Statement

Compare
8 Followers

Integrated BioPharma Income Statement

Last quarter (Q1 2026), Integrated BioPharma's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Integrated BioPharma's net income was $123.00K. See Integrated BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 54.35M$ 50.32M$ 50.67M$ 56.25M$ 63.56M
Gross Profit
$ 5.56M$ 3.88M$ 4.06M$ 6.55M$ 9.48M
Operating Expenses
$ 3.54M$ 3.63M$ 3.94M$ 3.81M$ 3.70M
Depreciation and Amortization
$ 1.27M$ 1.22M$ 1.15M$ 834.00K$ 826.00K
EBITDA
$ 3.38M$ 1.47M$ 1.27M$ 3.56M$ 6.61M
Operating Income
$ 2.02M$ 251.00K$ 120.00K$ 1.97M$ 5.78M
Other Income/Expenses
$ 42.00K$ 17.00K$ -20.00K$ -148.00K$ 1.46M
Pretax Income
$ 2.06M$ 268.00K$ 100.00K$ 2.60M$ 7.25M
Net Income
$ 808.00K$ 112.00K$ -34.00K$ 3.84M$ 8.01M
Per Share Metrics
Basic EPS
$ 0.03$ 0.00$ 0.00$ 0.13$ 0.27
Diluted EPS
$ 0.03$ 0.00$ 0.00$ 0.12$ 0.25
Weighted Average Shares Outstanding
30.30M 30.07M 29.95M 29.84M 29.70M
Weighted Average Shares Outstanding (Diluted)
31.17M 30.87M 29.95M 32.32M 32.11M
Currency in USD

Integrated BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis